Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-21-080833
Date:2021-06-10
Issuer: Y-MABS THERAPEUTICS, INC. (YMAB)
Original Submission Date:

Reporting Person:

BER GERARD
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE SUITE 3350 NEW YORK, NY 10169

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-EMPLOYEE STOCK OPTION (RIGHT TO BUY) 37.53 2021-06-10 deemed execution date A 16,000 (a) 2021-07-10 2031-06-10 common stock 16,000 $37.53 16,000 direct
Footnotes
IDfootnote
f1 stock options granted to the reporting person as a non-employee director pursuant to the 2018 equity incentive plan of y-mabs therapeutics, inc.
f2 the stock options vest in equal monthly installments during the first year following the date of grant, subject to the reporting person's continued service on the board of directors of y-mabs therapeutics, inc., and are exercisable immediately upon vesting.
WhaleWisdom Logo

Elevate your investments